Showing results (81-90 of 10,913) with videos related to
Sort By:
Pageof 1,092
Cancer|August 16, 2016
Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-upHannah Y Wen, Melissa Krystel-Whittemore, Sujata Patil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCL, in metastatic breast cancerP N Münster, A Buzdar, K Dhingra, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancerL Vahdat, G Raptis, D Fennelly, et al.Breast Cancer Research and Treatment|February 29, 2008
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)G G Kimmick, C Cirrincione, D B Duggan, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 8, 2011
The prostaglandin transporter regulates adipogenesis and aromatase transcriptionKotha Subbaramaiah, Clifford A Hudis, Andrew J DannenbergThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 1983
The development of peptidergic neurons in the foregut of the chickM L Epstein, J Hudis, J L DahlTherapeutic Advances in Medical Oncology|July 27, 2011
Bevacizumab in metastatic breast cancer: when may it be used?Shari B Goldfarb, Clifford Hudis, Maura N DicklerBreast Cancer Research and Treatment|September 8, 2011
Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancerDevika Gajria, Joseph Gonzalez, Kimberly Feigin, et al.Current Breast Cancer Reports|September 28, 2013
Omega-3 fatty acids for the prevention of breast cancer: an update and state of the scienceNeil M Iyengar, Clifford A Hudis, Ayca GucalpJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrheaChau Dang, Nancy Lin, Beverly Moy, et al.Pageof 1,092